Maria Kopsida
Researcher at Department of Medical Cell Biology; Research group Femke Heindryckx
- E-mail:
- maria.kopsida@mcb.uu.se
- Visiting address:
- BMC
Husargatan 3
751 23 Uppsala - Postal address:
- Box 571
751 23 UPPSALA
Publications
Recent publications
-
Part of FEBS Open Bio, 2026
- DOI for Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling
- Download full text (pdf) of Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling
-
Part of Therapeutic Advances in Medical Oncology, 2026
- DOI for Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients
- Download full text (pdf) of Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients
-
Part of Journal of Pharmaceutical and Biomedical Analysis, 2025
- DOI for Mapping the polar metabolome in Huh-7 liver cancer cells reveal the role of atorvastatin in enhancing chemotherapeutic efficacy of doxorubicin
- Download full text (pdf) of Mapping the polar metabolome in Huh-7 liver cancer cells reveal the role of atorvastatin in enhancing chemotherapeutic efficacy of doxorubicin
-
Part of Biomedicine and Pharmacotherapy, 2025
- DOI for A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma
- Download full text (pdf) of A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma
-
Part of Therapeutic Advances in Medical Oncology, p. 1-30, 2025
- DOI for Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
- Download full text (pdf) of Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
All publications
Articles in journal
-
Part of FEBS Open Bio, 2026
- DOI for Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling
- Download full text (pdf) of Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling
-
Part of Therapeutic Advances in Medical Oncology, 2026
- DOI for Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients
- Download full text (pdf) of Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients
-
Part of Journal of Pharmaceutical and Biomedical Analysis, 2025
- DOI for Mapping the polar metabolome in Huh-7 liver cancer cells reveal the role of atorvastatin in enhancing chemotherapeutic efficacy of doxorubicin
- Download full text (pdf) of Mapping the polar metabolome in Huh-7 liver cancer cells reveal the role of atorvastatin in enhancing chemotherapeutic efficacy of doxorubicin
-
Part of Biomedicine and Pharmacotherapy, 2025
- DOI for A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma
- Download full text (pdf) of A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma
-
Part of Therapeutic Advances in Medical Oncology, p. 1-30, 2025
- DOI for Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
- Download full text (pdf) of Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
-
Part of European Journal of Pharmacology, 2025
- DOI for Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives
- Download full text (pdf) of Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives
-
Part of Molecular Metabolism, 2024
- DOI for Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
- Download full text (pdf) of Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
-
Part of PLOS ONE, 2024
- DOI for Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoids
- Download full text (pdf) of Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoids
-
Part of Scientific Reports, 2023
- DOI for Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma
- Download full text (pdf) of Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma
-
The progression of doxorubicin-induced intestinal mucositis in rats
Part of Naunyn-Schmiedeberg's Archives of Pharmacology, p. 247-260, 2023
- DOI for The progression of doxorubicin-induced intestinal mucositis in rats
- Download full text (pdf) of The progression of doxorubicin-induced intestinal mucositis in rats
-
Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
Part of Cells, 2022
- DOI for Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
- Download full text (pdf) of Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
-
Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
Part of Cells, 2021
- DOI for Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
- Download full text (pdf) of Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
-
Part of Life Sciences, 2021
- DOI for Activated platelets contribute to the progression of hepatocellular carcinoma by altering the tumor environment
- Download full text (pdf) of Activated platelets contribute to the progression of hepatocellular carcinoma by altering the tumor environment
-
Part of International Journal of Molecular Sciences, 2020
- DOI for Inhibiting P2Y12 in Macrophages Induces Endoplasmic Reticulum Stress and Promotes an Anti-Tumoral Phenotype
- Download full text (pdf) of Inhibiting P2Y12 in Macrophages Induces Endoplasmic Reticulum Stress and Promotes an Anti-Tumoral Phenotype
Articles, review/survey
-
Endoplasmic Reticulum Stress and Metabolism in Hepatocellular Carcinoma
Part of American Journal of Pathology, p. 1377-1388, 2023